Regulatory Insights
-
Blueprint For Efficient Clinical Trial Disclosure
4/21/2025
Explore a comprehensive framework that helps organizations continuously assess and improve their clinical trial disclosure processes.
-
How The FDA Is Phasing Out Animal Testing Requirement
4/21/2025
The FDA is embarking on a transformative initiative to phase out animal testing requirements.
-
Key Update On Guideline For Good Clinical Practice E6(R3)
4/21/2025
Review details of the adoption of ICH GCP E6 R3 Principles and Annex 1, as well as what preparations and next steps your organization will need to undertake.
-
Accelerating Clinical Data Review With Traceable Workflows
4/17/2025
Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.
-
Tips For Navigating Tax Season As A 1099-MISC Recipient
4/16/2025
Explore the tax implications for individuals who received compensation for participating in clinical trials, specifically focusing on the issuance of the 1099-MISC.
-
Accelerate Your Oncology Breakthroughs
4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
Advancing Rare Disease Clinical Trials: A High-Touch, Patient-Centered Approach For Biotechs
4/15/2025
On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.
-
Global Trial Disclosure Landscape Grows Increasingly Complex
4/15/2025
The industry is witnessing a global trend toward increased transparency and more stringent enforcement of clinical trial reporting requirements. However mechanisms and penalties differ significantly across regions and countries.
-
Accelerate Respiratory Disease Trials: A Guide To Digital Endpoints
4/15/2025
Learn how wearables and DHTs are alleviating the trial participation burden, increasing the likelihood of trial success, and enhancing the overall management of these conditions.
-
Unlocking Continued Revenue And Growth From Established Products
4/14/2025
Gain insights into how pharmaceutical companies successfully handle post-approval regulatory upkeep for established products, focusing on reducing operational costs and expanding global market access.